Aralez Pharma (ARLZ) Halted on LUDP
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Stocks gear up for Big Tech earnings; yen toys with danger zone
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises on robust EU data as Mideast tensions linger
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
Guggenheim Reiterates Buy on Aralez Pharma (ARLZ) Following Yosprala Approval
September 15, 2016 4:00 PM EDTGuggenheim reiterated a Buy rating and $12.00 price target on Aralez Pharmaceuticals (NASDAQ: ARLZ) following the approval of Yosprala and the recent acquisition of Zontivity. Yosprala will complement ARLZ's Fibricor, which is another CV drug that ARLZ already markets, and Zontivity, which ARLZ recently acquired.... More
Aralez Pharma (ARLZ) Halted on LUDP
September 15, 2016 10:00 AM EDTAralez Pharma (NASDAQ: ARLZ) Halted on LUDP
... MoreAralez Pharma (ARLZ) will resume trading at 10:00am ET
September 15, 2016 9:44 AM EDTAralez Pharma (NASDAQ: ARLZ) will resume trading at 10:00am EDT.
... MoreAralez Pharma (ARLZ) Slammed, Halted Ahead of PDUFA Date
September 14, 2016 11:40 AM EDTAralez Pharma (NASDAQ: ARLZ) has resumed trading and is down 14%. Today is the company's PDUFA date for YOSPRALA.
... More
